Form 4: Exelixis Director Sells Shares After Option Exercise

Exelixis Director Bob Oliver exercised options and subsequently sold a portion of his common stock holdings.

Summary

• Bob Oliver, a Director at Exelixis, Inc. (EXEL), reported transactions on February 13, 2026, involving the exercise of options and subsequent sale of common stock.
• Oliver exercised options to acquire 9,088 shares of common stock at an exercise price of $19.28 per share.
• Concurrently, he sold 9,088 shares of common stock at a price of $43.61 per share.
• He also sold an additional 21,162 shares of common stock at a weighted average price of $43.90 per share, with individual transaction prices ranging from $43.90 to $43.96.
• Following these transactions, Oliver beneficially owns 21,120 shares of common stock directly, which includes 18,900 restricted stock units (RSUs) that are yet to vest.
• He also holds 12,118 derivative securities (options) directly.
• The option exercised on February 13, 2026, was part of a larger grant for 36,353 shares that became fully exercisable on May 31, 2023.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine insider transaction where a director exercised options and sold shares, likely for personal financial planning. The significant profit realized from the option exercise is positive for the individual, but the sale of shares by a director is generally viewed neutrally to slightly negatively by the market, though it's common for compensation.

Positives

• Director Bob Oliver realized a significant gain by exercising options at $19.28 per share and selling the acquired shares at prices between $43.61 and $43.96 per share.

Negatives

• Director Bob Oliver sold a total of 30,250 shares of common stock, reducing his direct common stock holdings (excluding RSUs) to 2,220 shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, such as option exercises followed by stock sales, are common events for corporate directors and executives, often related to compensation plans or personal financial management. These transactions are typically pre-scheduled under Rule 10b5-1 plans to avoid accusations of trading on material non-public information.

Stakeholder Impact

• Shareholders may note the director's decision to sell shares, which is a common occurrence for compensation and personal financial planning, and not necessarily indicative of a change in company outlook.

Key Dates

Keywords

EXEL, Exelixis, insider trading, Form 4, stock sale, option exercise, director compensation